Please note that there are more than 3 ways to pay a PI, but in this video I discuss several options that may work for your clinical research company.
The answer in short is: technically no, but practically yes. It really is as simple as that! Of course, every research company is different so act accordingly.
Ever wanted to lose a clinical trial? How about lose one in just under a month? Well folks, I’m here to tell you that it is possible, and actually happens more often than you might think. Usually Sponsors may terminate clinical research sites due to their lack of enrollment numbers, but there are also plenty of other sure-fire ways to get your Site booted! Check this video and please do NOT do anything that I mention!
There are actually two contingencies specifically, and a third thing to add to the contract. All are listed below. You get a prize for accomplishing any of these 3 things, just email me proof dan@theclinicaltrialsguru dot com. A special prize for anyone who manages to get all 3 done!
1. Remove the following contingency: “CRO will pay site monthly upon payment by the sponsor”. Instead add: “CRO will pay site monthly”.
2. Remove any language that says “in the event the CRO does not make payment the institution cannot seek funds from the sponsor”. You want to get your Site payments regardless of any situation or circumstance.
3. Finally, add “$500.00 Monitor change fee” added to every contract. It never ceases to amaze me how many different CRA changes a protocol can have that ultimately ends up delaying Site payments.
Accomplish any one of these three things, get a prize. Accomplish all three and get a statue built in your image in The Clinical Trials Guru studio! (or something comparable).
Last month I visited the Washington DC area and took a quick trip to the FDA headquarters. In this video, I explain what the FDA is looking at during Site audits to research clinics across the country. Just because your Site is following FDA guidelines does not mean the FDA will not have any findings at your Site. A major finding at many research clinics as of late is research Sites not following their own SOP’s. In other words, if your SOP’s are even more rigid than FDA guidelines, and you don’t follow them, the FDA will mark this as a finding.
In today’s video, I dive into a grab bag of viewer questions. There are several interesting topics discussed such as Clinical Trial StartUp Costs, the necessity of having appropriate insurance in place for your clinical research company, regulatory issues, recruitment topics, how to get more studies for your organization, and last but not least, why hustle is so important in clinical trials! I hope you find at least one valuable idea in this video.